US Patent 11359015 Humanized or chimeric CD3 antibodies
Patent 11359015 was granted and assigned to Genmab A/S on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11359015 Humanized or chimeric CD3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
